CYRX vs DHC
CYRX: Cryoport is the leading provider of end-to-end temperature-controlled supply chain solutions specifically built for cell and gene therapies, from preclinical development through global commercialization. DHC: Diversified Healthcare Trust is a REIT focused on owning and operating a broad portfolio of senior living, medical office, and life science real estate properties across the U.S.
Side-by-side fundamentals
| Metric | CYRX | DHC | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $15.15 | $8.90 | |
| Market cap as of 2026-08-03 | $764M | $2.2B | |
| P/E as of 2026-08-03 | 10.00 | n/a | |
| PEG as of 2026-08-03 | n/a | -0.75 | |
| Net margin as of 2026-08-03 | +41.6% | -21.1% | CYRX higher |
| Gross margin as of 2026-08-03 | +47.2% | +18.6% | CYRX higher |
| Operating margin as of 2026-08-03 | -21.4% | -11.8% | DHC higher |
| ROE as of 2026-08-03 | +15.0% | -18.8% | CYRX higher |
| ROA as of 2026-08-03 | +9.9% | -7.1% | CYRX higher |
| Debt / equity as of 2026-08-03 | 0.38 | 1.48 | CYRX lower |
| Revenue growth (YoY) as of 2026-08-03 | -14.8% | +0.4% | DHC higher |
| Revenue CAGR (3y) SEC XBRL | -9.4% | +6.2% | DHC higher |
| Dividend yield as of 2026-08-03 | n/a | +0.4% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-03 | 1.89 | 0.81 | |
| 1-year return as of 2026-07-27 close | +93.0% | +172.2% | DHC higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.